Introduction and importance: High-altitude illness (HAI) comprises a spectrum of disorders, including acute mountain sickness (AMS), high-altitude pulmonary edema (HAPE), and high-altitude cerebral edema (HACE). Although gradual ascent is the most effective preventive strategy, severe complications such as HAPE and HACE can still occur in susceptible individuals despite recommended ascent profiles. Case presentation: A 31-year-old male trekker in the Manang Valley (3350 m) developed HAPE and HACE despite gradual ascent and 6 days of acclimatization. He presented with severe headache, nausea, and shortness of breath. Examination showed cyanosis, SpO 2 39%, respiratory rate 35, bilateral lung crackles, and positive cerebellar signs. Prompt treatment with oxygen, dexamethasone, acetazolamide, and nifedipine led to improvement. He was airlifted to a lower altitude and fully recovered. Clinical discussion: Despite a gradual ascent and absence of comorbidities, the patient developed concurrent HAPE and HACE, illustrating that severe illness can occur even in low-risk profiles. This underscores the role of individual susceptibility and highlights the importance of maintaining a high index of suspicion in all high-altitude trekkers. Conclusion: This case illustrates that even with proper acclimatization and ascent, severe forms of HAI, such as HAPE and HACE, can occur. It underscores the role of individual vulnerability, possibly influenced by genetic and environmental factors, in the pathogenesis of altitude illness. Prompt recognition and early intervention are essential to prevent fatal outcomes.
Bhatta et al. (Tue,) studied this question.